Hamilton Bruce, Knez Wade, Eirale Cristiano, Chalabi Hakim
Division of Sports Medicine, ASPETAR, Qatar Orthopaedic and Sports Medicine Hospital, Doha, Qatar.
Acta Orthop Belg. 2010 Aug;76(4):443-8.
Hamstring muscle strains are among the most common injuries in sport, but despite increasing research into the epidemiology, aetiology and management the rates of both injury and re-injury remain high. Typically, hamstring injury management is conservative, but recently the use of autologous platelet enriched plasma (PEP), has been proposed as a treatment tool which may optimise muscle regeneration and enhance clinical outcomes. Unfortunately however, there remains little scientific evidence for the clinical use of these techniques in muscle injuries. This report outlines the current clinical evidence for the use of PEP in muscle injuries. A case report of a patient with a grade II semi-membranosus muscle strain, injected with PEP while concurrently using platelet inhibitors will illustrate the clinical, radiological and theoretical challenges of this new technique. Further clinical research into the clinical utility of PEP in muscle injury is required and it is incumbent on Sports Physicians and researchers to address this research deficit, if PEP is to live up to its high public profile.
腘绳肌拉伤是体育运动中最常见的损伤之一。尽管对其流行病学、病因学及治疗方法的研究不断增加，但损伤和再次损伤的发生率仍然很高。通常，腘绳肌损伤的治疗是保守的，但最近有人提出使用自体富血小板血浆（PEP）作为一种治疗手段，它可能会优化肌肉再生并改善临床疗效。然而，遗憾的是，目前几乎没有科学证据支持这些技术在肌肉损伤临床中的应用。本报告概述了目前使用PEP治疗肌肉损伤的临床证据。一名患有二级半膜肌拉伤的患者，在同时使用血小板抑制剂的情况下注射了PEP，其病例报告将说明这项新技术在临床、放射学及理论方面所面临的挑战。如果PEP想要不负其在公众中的高知名度，就需要对其在肌肉损伤临床应用中的效用进行进一步的临床研究，体育医生和研究人员有责任弥补这一研究不足。
